The outlook of companies tied to iconic drugs like Viagra presents a nuanced investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the loss of exclusivity in key regions has introduced substantial risk . Investors are now assessing the impact of generic competition here